Literature DB >> 17137764

Incorporation of water-soluble drugs in PLGA microspheres.

Fuminori Ito1, Hiroyuki Fujimori, Kimiko Makino.   

Abstract

Poly(lactide-co-glycolide) (PLGA) microspheres containing blue dextran, as a model of water-soluble drugs, were prepared from w(1)/o/w(2) emulsions by using a microhomogenizer and a solvent evaporation method. Effects of preparation conditions, such as, concentration of poly(vinyl alcohol) (PVA) in w(2) phase, viscosity of inner soluble water phase, volume ratio of oil phase to w(1) phase in primary emulsion, PLGA concentration in oil phase, and molecular weight or composition of PLGA, upon the properties of PLGA microspheres containing water-soluble drugs were examined. Concentration of poly(vinyl alcohol) (PVA), the dispersant dissolved in w(2) phase of secondary emulsion did not show any effects on the final particle size. On the other hand, volume ratio of oil phase to water one in primary emulsion affected the final particle size, which seemed to be related to the local PLGA concentration in w(1)/o emulsions. That is, the particle size increased as the volume ratio of w(1) phase against oil phase, w(1)/o (v/v), increased. The loading efficiency, however, was not affected by the volume ratio of w(1)/o (v/v), but affected by blue dextran concentration in w(1) phase. Higher loading efficiency was observed in PLGA microspheres prepared from w(1) phase containing lower concentration of blue dextran. Blue dextran solution (inner water phase) with the lower viscosity may result in the lower leakage ratio of blue dextran during the preparation procedure. Increases in concentration and molecular weight of PLGA made particle size larger.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17137764     DOI: 10.1016/j.colsurfb.2006.10.019

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  7 in total

1.  Cephalexin microspheres for dairy mastitis: effect of preparation method and surfactant type on physicochemical properties of the microspheres.

Authors:  Wasana Chaisri; Wim E Hennink; Chadarat Ampasavate; Siriporn Okonogi
Journal:  AAPS PharmSciTech       Date:  2010-05-29       Impact factor: 3.246

2.  Enhanced endothelialization of a new stent polymer through surface enhancement and incorporation of growth factor-delivering microparticles.

Authors:  Hao Xu; Kytai T Nguyen; Emmanouil S Brilakis; Jian Yang; Eric Fuh; Subhash Banerjee
Journal:  J Cardiovasc Transl Res       Date:  2012-05-26       Impact factor: 4.132

Review 3.  Nanotechnology for delivery of drugs to the brain for epilepsy.

Authors:  Margaret F Bennewitz; W Mark Saltzman
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

4.  Co-delivery of glial cell-derived neurotrophic factor (GDNF) and tauroursodeoxycholic acid (TUDCA) from PLGA microspheres: potential combination therapy for retinal diseases.

Authors:  Alicia Arranz-Romera; Sergio Esteban-Pérez; Irene T Molina-Martínez; Irene Bravo-Osuna; Rocío Herrero-Vanrell
Journal:  Drug Deliv Transl Res       Date:  2021-02-27       Impact factor: 4.617

5.  Continuous in-line homogenization process for scale-up production of naltrexone-loaded PLGA microparticles.

Authors:  Farrokh Sharifi; Andrew Otte; Gwangheum Yoon; Kinam Park
Journal:  J Control Release       Date:  2020-07-07       Impact factor: 11.467

Review 6.  Theranostic applications of nanoparticles in neurodegenerative disorders.

Authors:  Sahana Ramanathan; Govindaraju Archunan; Muthusamy Sivakumar; Subramanian Tamil Selvan; A Lenin Fred; Sundramurthy Kumar; Balázs Gulyás; Parasuraman Padmanabhan
Journal:  Int J Nanomedicine       Date:  2018-09-20

7.  The Effect of Polymer Microstructure on Encapsulation Efficiency and Release Kinetics of Citropin 1.1 from the Poly(ε-caprolactone) Microparticles.

Authors:  Urszula Piotrowska; Ewa Oledzka; Wojciech Kamysz; Sławomir Białek; Marcin Sobczak
Journal:  Nanomaterials (Basel)       Date:  2018-06-30       Impact factor: 5.076

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.